sentence1 stringlengths 1.08k 96.5k | sentence2 stringlengths 51 966 | labels stringclasses 3
values | metadata stringlengths 123 2.56k |
|---|---|---|---|
Background
The purpose of this clinical study is to evaluate the feasibility of using 2-mm laparoscopic instruments to perform an appendectomy in patients with clinically suspected acute appendicitis and compare the outcome of this mini-laparoscopic or "needlescopic" approach to the conventional laparoscopic appendect... | Intervention: needlescopic appendectomy
Comparator: laparoscopic appendectomy
Outcome: mean operative time | -1 | {"evidence_spans": [{"end": 1251, "start": 1170, "text": "group. The needlescopic group had a significantly shorter mean operative time (p "}, {"end": 8057, "start": 7815, "text": "ferent when comparing the two groups (Table 2). The mean operative time was 55 minutes (range, 45\u201365 minutes) for the needlescopic gro... |
Background
The purpose of this clinical study is to evaluate the feasibility of using 2-mm laparoscopic instruments to perform an appendectomy in patients with clinically suspected acute appendicitis and compare the outcome of this mini-laparoscopic or "needlescopic" approach to the conventional laparoscopic appendect... | Intervention: needlescopic appendectomy
Comparator: laparoscopic appendectomy
Outcome: The mean in-hospital use of narcotic analgesia | 0 | {"evidence_spans": [{"end": 8693, "start": 8492, "text": "a- or post-operative complications occurred with either technique. The mean in-hospital use of narcotic analgesia as measured in MSO4 equivalent was 11 mg in the patients who underwent needlescopic app"}], "id": "11377", "pmcid": "59899", "prompt_id": "11377", "... |
Background
The purpose of this clinical study is to evaluate the feasibility of using 2-mm laparoscopic instruments to perform an appendectomy in patients with clinically suspected acute appendicitis and compare the outcome of this mini-laparoscopic or "needlescopic" approach to the conventional laparoscopic appendect... | Intervention: needlescopic appendectomy
Comparator: laparoscopic appendectomy
Outcome: Mean days to return to work or normal activities | -1 | {"evidence_spans": [{"end": 1424, "start": 1170, "text": "group. The needlescopic group had a significantly shorter mean operative time (p = 0.02), reduced postoperative narcotics requirements (p = 0.05), shorter hospital stay (p = 0.04), and quicker return to work (p = 0.03) when compared with the laparoscopic"}], "id... |
Background
The purpose of this clinical study is to evaluate the feasibility of using 2-mm laparoscopic instruments to perform an appendectomy in patients with clinically suspected acute appendicitis and compare the outcome of this mini-laparoscopic or "needlescopic" approach to the conventional laparoscopic appendect... | Intervention: needlescopic appendectomy
Comparator: laparoscopic appendectomy
Outcome: Mean length of hospital stay (days) | -1 | {"evidence_spans": [{"end": 1424, "start": 1170, "text": "group. The needlescopic group had a significantly shorter mean operative time (p = 0.02), reduced postoperative narcotics requirements (p = 0.05), shorter hospital stay (p = 0.04), and quicker return to work (p = 0.03) when compared with the laparoscopic"}, {"en... |
Background
The most prominent feature of melancholic depression is a near-total loss of the capacity to derive pleasure from activities or other positive stimuli. Additional symptoms can include psychomotor disturbances, anorexia, excessive guilt, and early awakening from sleep. Melancholic patients may exhibit treatm... | Intervention: duloxetine (40–120 mg/d) for melancholic and non-melancholic patients
Comparator: placebo for melancholic and non-melancholic patients
Outcome: depressive symptom severity | -1 | {"evidence_spans": [{"end": 1824, "start": 1609, "text": "icant). Duloxetine demonstrated significantly greater improvement in depressive symptom severity, compared with placebo, within both melancholic and non-melancholic cohorts (p \u2264 .001 for HAMD17 total score, CGI-S an"}, {"end": 1826, "start": 1610, "text": "... |
Background
The most prominent feature of melancholic depression is a near-total loss of the capacity to derive pleasure from activities or other positive stimuli. Additional symptoms can include psychomotor disturbances, anorexia, excessive guilt, and early awakening from sleep. Melancholic patients may exhibit treatm... | Intervention: duloxetine (40–120 mg/d) male melancholic patients
Comparator: duloxetine (40–120 mg/d) female melancholic patients
Outcome: the magnitude of improvement in efficacy outcomes | 0 | {"evidence_spans": [{"end": 1994, "start": 1826, "text": "PGI-I). When analyzed by gender, the magnitude of improvement in efficacy outcomes did not differ significantly between duloxetine-treated male and female melancholic p"}, {"end": 1995, "start": 1827, "text": "GI-I). When analyzed by gender, the magnitude of imp... |
Background
The most prominent feature of melancholic depression is a near-total loss of the capacity to derive pleasure from activities or other positive stimuli. Additional symptoms can include psychomotor disturbances, anorexia, excessive guilt, and early awakening from sleep. Melancholic patients may exhibit treatm... | Intervention: duloxetine (60 mg/d) for melancholic patients
Comparator: placebo for melancholic patients
Outcome: severity of symptoms according to Hamilton Rating Scale for Depression (HAMD17) total score, the Clinical Global Impression of Severity (CGI-S) and Patient Global Impression of Improvement (PGI-I) scales | -1 | {"evidence_spans": [{"end": 2273, "start": 1995, "text": "tients. In the two studies that assessed duloxetine 60 mg once-daily dosing, duloxetine-treated melancholic patients had significantly greater improvement compared with placebo on HAMD17 total score, CGI-S, PGI-I, 3 of 4 subscales of the HAMD17, and VAS overall ... |
Background
The most prominent feature of melancholic depression is a near-total loss of the capacity to derive pleasure from activities or other positive stimuli. Additional symptoms can include psychomotor disturbances, anorexia, excessive guilt, and early awakening from sleep. Melancholic patients may exhibit treatm... | Intervention: duloxetine (60 mg/d) for melancholic patients
Comparator: placebo for melancholic patients
Outcome: Estimated probabilities of response and remission | 1 | {"evidence_spans": [{"end": 2529, "start": 2275, "text": " .01). Estimated probabilities of response and remission were significantly greater for melancholic patients receiving duloxetine 60 mg QD compared with placebo (response 74.7% vs. 42.2%, respectively, p < .001; remission 44.4% vs. 24.7%, respectively, p"}], "id... |
Background
Large-scale RCTs comparing different types of exercise training in institutionalised older people are scarce, especially regarding effects on habitual physical activity and constipation. This study investigated the effects of different training protocols on habitual physical activity and constipation of old... | Intervention: 1) resistance training; 2) all-round functional-skills training;
Comparator: 3) both; 4) an 'educational' control condition.
Outcome: total physical activity (min/d),total moderate activity (min/d), Time spent sitting (min/d), total counts per day, counts per minute | 0 | {"evidence_spans": [{"end": 1173, "start": 1061, "text": "tives. There were no between-group differences for changes in habitual physical activity or constipation over 6-"}, {"end": 18053, "start": 17526, "text": "n group difference at baseline\r\nThe differences in the 6 months change between the three exercise groups... |
Objective:
To determine the effect of the prokinetic agent cisapride in the
prevention of aspiration of gastric contents.
Design:
A prospective randomized two-period crossover study.
Setting:
Fourteen-bed polyvalent intensive care unit in a University
Hospital.
Patients:
Eighteen intubated, mecha... | Intervention: cisapride (10 mg, via nasogastric tube)
Comparator: placebo
Outcome: The cumulative bronchial secretion radioactivity | -1 | {"evidence_spans": [{"end": 1376, "start": 1164, "text": " those receiving a placebo. The cumulative bronchial secretion radioactivity\r\n\t\t\t\tobtained when patients received cisapride was significantly lower than when\r\n\t\t\t\tpatients received a placebo: 7540 \u00b1 5330 and 2196"}], "id": "11388", "pmcid": "290... |
Introduction
Combination antibiotic therapy for ventilator associated pneumonia (VAP) is often used to broaden the spectrum of activity of empirical treatment. The relevance of such synergy is commonly supposed but poorly supported. The aim of the present study was to compare the clinical outcome and the course of bio... | Intervention: cefepime (C group), cefepime with amikacin (C-A group)
Comparator: cefepime with levofloxacin (C-L group)
Outcome: length of stay in the intensive care unit after infection | 0 | {"evidence_spans": [{"end": 1238, "start": 1147, "text": "level. There were no differences between length of stay in the intensive care unit after in"}, {"end": 11518, "start": 11257, "text": "and one methicillin-resistant S. aureus).\r\nThe length of ICU stay after the occurrence of infection was not different between... |
Introduction
Combination antibiotic therapy for ventilator associated pneumonia (VAP) is often used to broaden the spectrum of activity of empirical treatment. The relevance of such synergy is commonly supposed but poorly supported. The aim of the present study was to compare the clinical outcome and the course of bio... | Intervention: cefepime (C group), cefepime with amikacin (C-A group)
Comparator: cefepime with levofloxacin (C-L group)
Outcome: ventilator free days | 0 | {"evidence_spans": [{"end": 11752, "start": 11519, "text": ") for groups C, C-A and C-L, respectively. There was also no difference between VFDs within 28 days after infection: the number of VFDs for each group was 16.1 \u00b1 8.3 VFDs after C treatment, 12.6 \u00b1 8.1 VFD after C-A treatment and 12.6"}], "id": "11390... |
Introduction
Combination antibiotic therapy for ventilator associated pneumonia (VAP) is often used to broaden the spectrum of activity of empirical treatment. The relevance of such synergy is commonly supposed but poorly supported. The aim of the present study was to compare the clinical outcome and the course of bio... | Intervention: cefepime (C group), cefepime with amikacin (C-A group)
Comparator: cefepime with levofloxacin (C-L group)
Outcome: the time course of temperature, leukocytosis or C-reactive protein level | 0 | {"evidence_spans": [{"end": 1146, "start": 1024, "text": "ents). No significant difference was observed regarding the time course of temperature, leukocytosis or C-reactive protein"}], "id": "11391", "pmcid": "1550875", "prompt_id": "11391", "split_group_id": "1550875", "votes": {"0": 2}} |
Background
Dietary nucleotide supplementation has been shown to have important effects on the growth and development of cells which have a rapid turnover such as those in the immune system and the gastrointestinal tract. Work with infants has shown that the incidence and duration of diarrhoea is lower when nucleotide ... | Intervention: Dietary nucleotides
Comparator: placebo
Outcome: diarrhoea, bloating and flatulence | 0 | {"evidence_spans": [{"end": 1920, "start": 1804, "text": "ement. The differences between conditions for diarrhoea, bloating and flatulence were not significant at the p < .05"}], "id": "11392", "pmcid": "1513247", "prompt_id": "11392", "split_group_id": "1513247", "votes": {"0": 2}} |
Background
Dietary nucleotide supplementation has been shown to have important effects on the growth and development of cells which have a rapid turnover such as those in the immune system and the gastrointestinal tract. Work with infants has shown that the incidence and duration of diarrhoea is lower when nucleotide ... | Intervention: Dietary nucleotides
Comparator: placebo
Outcome: anxiety, depression, illness intrusiveness and general health | -1 | {"evidence_spans": [{"end": 1720, "start": 1545, "text": "sults\r\nSymptom severity for all symptoms (except constipation) were in the expected direction of baseline>placebo>experimental condition. Symptom improvement was in the range "}], "id": "11393", "pmcid": "1513247", "prompt_id": "11393", "split_group_id": "1513... |
The blood-nourishing and hard-softening (BNHS) capsule is a traditional Chinese formula used in the symptomatic treatment of inflammation and pain. We conducted this randomized controlled trial to compare the efficacy of BNHS with other commonly prescribed drugs. We recruited 120 patients from two teaching hospitals; 3... | Intervention: The blood-nourishing and hard-softening (BNHS) capsule
Comparator: (chondroprotection drug/Viartril-s) - control
Outcome: stiffness and functional ability | 0 | {"evidence_spans": [{"end": 1346, "start": 1219, "text": "No significant differences were found in any of the outcome measures between the BNHS group and either of the comparison groups"}, {"end": 1347, "start": 1219, "text": "No significant differences were found in any of the outcome measures between the BNHS group a... |
The blood-nourishing and hard-softening (BNHS) capsule is a traditional Chinese formula used in the symptomatic treatment of inflammation and pain. We conducted this randomized controlled trial to compare the efficacy of BNHS with other commonly prescribed drugs. We recruited 120 patients from two teaching hospitals; 3... | Intervention: The blood-nourishing and hard-softening (BNHS) capsule
Comparator: (chondroprotection drug/Viartril-s) - control
Outcome: severe adverse effects | 0 | {"evidence_spans": [{"end": 1388, "start": 1348, "text": "No severe adverse effects were reported."}, {"end": 13928, "start": 13748, "text": "nsidered serious by the investigators. No severe adverse cardiovascular events or deep vein thrombosis were observed. No hospitalization or death occurred due to adverse events. ... |
Pancreatic cancer is a largely chemo-resistant disease with a poor prognosis. Despite the adoption of gemcitabine monotherapy as a standard of care, outcomes remain poor. Until recently randomized phase III studies have not demonstrated superiority of various cytotoxic combinations or a number of the newer biologic tar... | Intervention: Erlotinb in combination with gemcitabine
Comparator: gemcitabine monotherapy
Outcome: survival | 1 | {"evidence_spans": [{"end": 984, "start": 798, "text": " A randomized phase III study in locally advanced and metastatic pancreatic cancer has shown a survival advantage for the combination of gemcitabine plus erlotinib over gemcitabine alone"}, {"end": 33803, "start": 33334, "text": " Saltz 2005). Not only the presenc... |
Background
Clinical events committees (CEC) are used routinely to adjudicate suspected end-points in cardiovascular trials, but little information has been published about the various processes used. We reviewed results of the CEC process used to identify and adjudicate suspected end-point (post-enrolment) myocardial ... | Intervention: eptifibatide
Comparator: placebo
Outcome: the incidence of death or MI | -1 | {"evidence_spans": [{"end": 9974, "start": 9848, "text": "ified more end-point events than did the site investigators (Table 2). Eptifibatide reduced the incidence of death or MI in th"}], "id": "11398", "pmcid": "57749", "prompt_id": "11398", "split_group_id": "57749", "votes": {"-1": 2}} |
Background
Uncertainty remains about the potential harmful effects of antihypertensive therapy on the developing fetus, especially for beta-blockers (βb).
Methods
We prospectively enrolled all singleton women with a blood pressure ≥ 140/90 mm Hg during pregnancy. The main analysis included 1948 women with all form... | Intervention: beta-blockers (βb)
Comparator: non-βb drugs
Outcome: gestational age birthweight (SGA | 0 | {"evidence_spans": [{"end": 15968, "start": 15770, "text": "s, history of hypertension in a previous pregnancy, cigarette smoking, pre-pregnancy diabetes mellitus, pre-pregnancy renal dysfunction, use of prednisone, receipt of betamethasone for fetal lung ma"}], "id": "11399", "pmcid": "60658", "prompt_id": "11399", "s... |
Previous studies have found beneficial effects of aromatherapy massage for agitation in people with dementia, for pain relief and for poor sleep. Children with autism often have sleep difficulties, and it was thought that aromatherapy massage might enable more rapid sleep onset, less sleep disruption and longer sleep d... | Intervention: aromatherapy massage with lavender oil
Comparator: massage without lavender oil
Outcome: times at which individual children fell asleep | 1 | {"evidence_spans": [{"end": 8353, "start": 8102, "text": "= 4.15, 41.5; P = 0.30). There was however a significant participant effect suggesting that there were systematic differences in the times at which individual children fell asleep (F = 59.83; df = 1, 10; P < 0.001; meansleep onset time range 9:30 p.m."}], "id": ... |
Previous studies have found beneficial effects of aromatherapy massage for agitation in people with dementia, for pain relief and for poor sleep. Children with autism often have sleep difficulties, and it was thought that aromatherapy massage might enable more rapid sleep onset, less sleep disruption and longer sleep d... | Intervention: aromatherapy massage with lavender oil
Comparator: massage without lavender oil
Outcome: sleep durations | 0 | {"evidence_spans": [{"end": 9023, "start": 8780, "text": "0.19; df = 16; P = 0.21).\r\nThe length of time the children were asleep was also subject to a repeated measures analysis of variance which showed that there was no significant difference between the nights with and without aromatherapy (F = 0.5"}], "id": "11409... |
Background
To study the effects of Beta-blockers during Dobutamine Stress Echocardiography (DSE) comparing the hemodynamic benefits of an early administration of atropine in patients taking or not Beta-blockers.
Methods
One hundred and twenty-one patients were submitted to dobutamine stress echocardiography for th... | Intervention: A or B (early protocol when atropine was administered at 10 and 20 mcg/kg/min of dobutamine, respectively)
Comparator: group who were not Beta-blocked
Outcome: double product | -1 | {"evidence_spans": [{"end": 989, "start": 875, "text": "sults\r\nBeta-blocked patients who received early atropine (Group A&B) had a significantly lower double product (p ="}], "id": "11410", "pmcid": "1578590", "prompt_id": "11410", "split_group_id": "1578590", "votes": {"-1": 2}} |
Background
To study the effects of Beta-blockers during Dobutamine Stress Echocardiography (DSE) comparing the hemodynamic benefits of an early administration of atropine in patients taking or not Beta-blockers.
Methods
One hundred and twenty-one patients were submitted to dobutamine stress echocardiography for th... | Intervention: A or B (early protocol when atropine was administered at 10 and 20 mcg/kg/min of dobutamine, respectively)
Comparator: group who were not Beta-blocked
Outcome: mean test time | 1 | {"evidence_spans": [{"end": 1026, "start": 875, "text": "sults\r\nBeta-blocked patients who received early atropine (Group A&B) had a significantly lower double product (p = 0.008), a higher mean test time (p ="}, {"end": 1149, "start": 875, "text": "sults\r\nBeta-blocked patients who received early atropine (Group A&B... |
Background
To study the effects of Beta-blockers during Dobutamine Stress Echocardiography (DSE) comparing the hemodynamic benefits of an early administration of atropine in patients taking or not Beta-blockers.
Methods
One hundred and twenty-one patients were submitted to dobutamine stress echocardiography for th... | Intervention: A or B (early protocol when atropine was administered at 10 and 20 mcg/kg/min of dobutamine, respectively)
Comparator: group who were not Beta-blocked
Outcome: dose of atropine | 1 | {"evidence_spans": [{"end": 1149, "start": 875, "text": "sults\r\nBeta-blocked patients who received early atropine (Group A&B) had a significantly lower double product (p = 0.008), a higher mean test time (p = 0.010) and required a higher dose of atropine (p = 0.0005) when compared to the patients in this group who we... |
Background
To study the effects of Beta-blockers during Dobutamine Stress Echocardiography (DSE) comparing the hemodynamic benefits of an early administration of atropine in patients taking or not Beta-blockers.
Methods
One hundred and twenty-one patients were submitted to dobutamine stress echocardiography for th... | Intervention: C (standard protocol with atropine at 40 mcg/kg/min of dobutamine)
Comparator: A or B (early protocol when atropine was administered at 10 and 20 mcg/kg/min of dobutamine, respectively)
Outcome: Complications | 0 | {"evidence_spans": [{"end": 10806, "start": 10716, "text": "a significantly higher proportion of negative results than those taking Beta-blockers. On "}], "id": "11413", "pmcid": "1578590", "prompt_id": "11413", "split_group_id": "1578590", "votes": {"0": 2}} |
Background
To study the effects of Beta-blockers during Dobutamine Stress Echocardiography (DSE) comparing the hemodynamic benefits of an early administration of atropine in patients taking or not Beta-blockers.
Methods
One hundred and twenty-one patients were submitted to dobutamine stress echocardiography for th... | Intervention: A or B (early protocol when atropine was administered at 10 and 20 mcg/kg/min of dobutamine, respectively), C (standard protocol with atropine at 40 mcg/kg/min of dobutamine)
Comparator: baseline
Outcome: test time | 1 | {"evidence_spans": [{"end": 1212, "start": 875, "text": "sults\r\nBeta-blocked patients who received early atropine (Group A&B) had a significantly lower double product (p = 0.008), a higher mean test time (p = 0.010) and required a higher dose of atropine (p = 0.0005) when compared to the patients in this group who we... |
Background
We have shown that intravenous adenosine in normal subjects does not cause bronchospasm, but causes dyspnea, most likely by an effect on vagal C fibers in the lungs [Burki et al. J Appl Physiol 2005; 98:180-5]. Since airways inflammation and bronchial hyperreactivity are features of asthma, it is possible t... | Intervention: 10 mg intravenous adenosine - Normals
Comparator: 10 mg intravenous adenosine - Asthmatics
Outcome: forced expiratory spirogram | 0 | {"evidence_spans": [{"end": 858, "start": 597, "text": "sults\r\nPlacebo injection had no significant (p > 0.05) effect on the forced expiratory spirogram, heart rate, minute ventilation (Ve), or respiratory sensation. Similarly, adenosine injection caused no significant changes (p > 0.05) in the forced expiratory spi"... |
Background
We have shown that intravenous adenosine in normal subjects does not cause bronchospasm, but causes dyspnea, most likely by an effect on vagal C fibers in the lungs [Burki et al. J Appl Physiol 2005; 98:180-5]. Since airways inflammation and bronchial hyperreactivity are features of asthma, it is possible t... | Intervention: 10 mg intravenous adenosine - Normals
Comparator: 10 mg intravenous adenosine - Asthmatics
Outcome: tachycardia | 1 | {"evidence_spans": [{"end": 1125, "start": 859, "text": "ogram; however, there was a rapid development of dyspnea as signified visually on a modified Borg scale, and a significant (p < 0.05) tachycardia in each subject (Asthmatics +18%, Normals + 34%), and a significant (p < 0.05) increase in Ve (Asthmatics +93%, Norma... |
Background
We have shown that intravenous adenosine in normal subjects does not cause bronchospasm, but causes dyspnea, most likely by an effect on vagal C fibers in the lungs [Burki et al. J Appl Physiol 2005; 98:180-5]. Since airways inflammation and bronchial hyperreactivity are features of asthma, it is possible t... | Intervention: 10 mg intravenous adenosine - Normals
Comparator: 10 mg intravenous adenosine - Asthmatics
Outcome: minute ventilation (Ve) | 0 | {"evidence_spans": [{"end": 8041, "start": 7940, "text": "tidal CO2, SaO2 or HR, and no subject indicated any change in the Borg score.\r\nOn the other hand, ade"}], "id": "11419", "pmcid": "1693563", "prompt_id": "11419", "split_group_id": "1693563", "votes": {"0": 1}} |
Background
We have shown that intravenous adenosine in normal subjects does not cause bronchospasm, but causes dyspnea, most likely by an effect on vagal C fibers in the lungs [Burki et al. J Appl Physiol 2005; 98:180-5]. Since airways inflammation and bronchial hyperreactivity are features of asthma, it is possible t... | Intervention: 10 mg intravenous adenosine - Asthmatics
Comparator: 10 mg intravenous adenosine - Normals
Outcome: intensity of dyspnea | 1 | {"evidence_spans": [{"end": 1213, "start": 1125, "text": "+130%). The intensity of dyspnea was significantly greater (p < 0.05) in the asthmatic s"}, {"end": 1214, "start": 1126, "text": "130%). The intensity of dyspnea was significantly greater (p < 0.05) in the asthmatic su"}], "id": "11420", "pmcid": "1693563", "pro... |
Background
Vasectomy techniques have been the subject of relatively few rigorous studies. The objective of this analysis was to compare the effectiveness of two techniques for vas occlusion: intraluminal cautery versus ligation and excision with fascial interposition. More specifically, we aimed to compare early failu... | Intervention: intraluminal cautery
Comparator: ligation and excision with fascial interposition
Outcome: early failures | -1 | {"evidence_spans": [{"end": 12858, "start": 12643, "text": "wo studies.\r\n\r\nAnalysis of early failures\r\nWe found significantly fewer early failures in the cautery study than in the fascial interposition group from the randomized controlled trial: 1.0% (4/389) versus 4.9% (20/"}, {"end": 13031, "start": 12643, "tex... |
Background
Vasectomy techniques have been the subject of relatively few rigorous studies. The objective of this analysis was to compare the effectiveness of two techniques for vas occlusion: intraluminal cautery versus ligation and excision with fascial interposition. More specifically, we aimed to compare early failu... | Intervention: intraluminal cautery
Comparator: ligation and excision with fascial interposition
Outcome: severe oligozoospermia | 1 | {"evidence_spans": [{"end": 13916, "start": 13695, "text": "0 weeks after the procedure.\r\n\r\nTime to success\r\nLife-table analyses of time to success showed that the participants in the cautery study reached severe oligozoospermia significantly more rapidly than did those in the fas"}], "id": "11422", "pmcid": "529... |
Background
Long-menu questions (LMQs) are viewed as an alternative method for answering open-ended questions (OEQs) in computerized assessment. So far this question type and its influence on examination scores have not been studied sufficiently. However, the increasing use of computerized assessments will also lead to... | Intervention: Long-menu questions (LMQs)
Comparator: open-ended questions (OEQs)
Outcome: The average number of correct answers | 0 | {"evidence_spans": [{"end": 1163, "start": 1063, "text": "esults\r\nThe average number of correct answers for LMQs and OEQs showed no significant difference (p "}], "id": "11428", "pmcid": "1618389", "prompt_id": "11428", "split_group_id": "1618389", "votes": {"0": 2}} |
Background
Long-menu questions (LMQs) are viewed as an alternative method for answering open-ended questions (OEQs) in computerized assessment. So far this question type and its influence on examination scores have not been studied sufficiently. However, the increasing use of computerized assessments will also lead to... | Intervention: Long-menu questions (LMQs)
Comparator: open-ended questions (OEQs)
Outcome: The response time | 0 | {"evidence_spans": [{"end": 1345, "start": 1260, "text": "nswers. The response time for LMQs did not significantly differ from that of OEQs (p "}, {"end": 12098, "start": 11950, "text": "answer and not on possible entries into the OE text cell. Mean response time for LMQs was 101 seconds (SD 32), compared with 107 seco... |
Background
hyperlipidemia as a major risk factor of atherosclerosis is treated with different drugs. Concerning length of therapy and vast majority of side effects, herbal medication may be suitable substitute for these drugs.
Methods
In this single-blind, placebo controlled study, lipid profiles of 150 hyperlipid... | Intervention: garlic powder tablet (equal to 400 mg garlic, 1 mg allicin)
Comparator: baseline
Outcome: triglyceride | 0 | {"evidence_spans": [{"end": 1177, "start": 1066, "text": "eased. Although triglyceride dropped by 13.72 mg/dl (6.3%) but this was not significant statistically (P-value:"}], "id": "11433", "pmcid": "1821028", "prompt_id": "11433", "split_group_id": "1821028", "votes": {"0": 2}} |
Background
hyperlipidemia as a major risk factor of atherosclerosis is treated with different drugs. Concerning length of therapy and vast majority of side effects, herbal medication may be suitable substitute for these drugs.
Methods
In this single-blind, placebo controlled study, lipid profiles of 150 hyperlipid... | Intervention: anethum tablet (650 mg)
Comparator: baseline
Outcome: total cholesterol and LDL-cholesterol | 0 | {"evidence_spans": [{"end": 1416, "start": 1255, "text": "(6.0%). Anethum could reduce total cholesterol by 0.4 % and LDL-cholesterol by 6.3% but these were not significant statistically (P-value: .828, and .210, respec"}, {"end": 1417, "start": 1256, "text": "6.0%). Anethum could reduce total cholesterol by 0.4 % and ... |
Background
Highly active antiretroviral treatment (HAART) has only been recently recommended for HIV-infected pregnant women requiring treatment for their own health in resource-limited settings. However, there are few documented experiences from African countries. We evaluated the short-term (4 wk) and long-term (12 ... | Intervention: Highly active antiretroviral treatment (HAART) group
Comparator: antiretroviral (scARV) prevention of mother-to-child transmission of HIV (PMTCT)
Outcome: infants were diagnosed as HIV-infected | 0 | {"evidence_spans": [{"end": 23338, "start": 23130, "text": " HAART group and 3.1% (95% CI 0.1%\u20136.1%) in the scARV for PMTCT group (Table 4). At 12 mo, 5.7% (95% CI 2.5%\u20139.0%) of the infants were diagnosed as HIV-infected: 3.3% (95% CI 0.0%\u20136.9%) in the HAART group and"}, {"end": 23339, "start": 23131, "t... |
Background
Highly active antiretroviral treatment (HAART) has only been recently recommended for HIV-infected pregnant women requiring treatment for their own health in resource-limited settings. However, there are few documented experiences from African countries. We evaluated the short-term (4 wk) and long-term (12 ... | Intervention: Highly active antiretroviral treatment (HAART) group
Comparator: antiretroviral (scARV) prevention of mother-to-child transmission of HIV (PMTCT)
Outcome: infant feeding practice | 0 | {"evidence_spans": [{"end": 23442, "start": 23340, "text": ".5% (95% CI 2.8%\u201312.3%) in the scARV for PMTCT group (log-rank test, p = 0.18). No statistically signi"}], "id": "11436", "pmcid": "1949842", "prompt_id": "11436", "split_group_id": "1949842", "votes": {"0": 2}} |
Background
Highly active antiretroviral treatment (HAART) has only been recently recommended for HIV-infected pregnant women requiring treatment for their own health in resource-limited settings. However, there are few documented experiences from African countries. We evaluated the short-term (4 wk) and long-term (12 ... | Intervention: Highly active antiretroviral treatment (HAART) group
Comparator: antiretroviral (scARV) prevention of mother-to-child transmission of HIV (PMTCT)
Outcome: the rate of postnatal transmission | 0 | {"evidence_spans": [{"end": 25805, "start": 25594, "text": "6 infants (3.5% [95% CI 0.7%\u20139.9%]) breast-fed for a median of 5.7 mo (IQR 4.3\u20137.1 mo). If we hypothesize that the three cases with unknown timing are possible postnatal cases, the rate of postnatal transmission"}], "id": "11437", "pmcid": "1949842",... |
Background
Highly active antiretroviral treatment (HAART) has only been recently recommended for HIV-infected pregnant women requiring treatment for their own health in resource-limited settings. However, there are few documented experiences from African countries. We evaluated the short-term (4 wk) and long-term (12 ... | Intervention: Highly active antiretroviral treatment (HAART) group
Comparator: antiretroviral (scARV) prevention of mother-to-child transmission of HIV (PMTCT)
Outcome: The overall probability of HIV infection or death among infants aged 12 mo | 0 | {"evidence_spans": [{"end": 26570, "start": 26215, "text": "003\u20132006\r\n\r\n12-Month Infant HIV-Free Survival and Death According to Maternal ARV Regimens\r\nThe overall probability of HIV infection or death among infants aged 12 mo of all women enrolled in this study was 11.7% (95% CI 7.5%\u201315.9%); the probab... |
Background
Highly active antiretroviral treatment (HAART) has only been recently recommended for HIV-infected pregnant women requiring treatment for their own health in resource-limited settings. However, there are few documented experiences from African countries. We evaluated the short-term (4 wk) and long-term (12 ... | Intervention: Highly active antiretroviral treatment (HAART) group
Comparator: antiretroviral (scARV) prevention of mother-to-child transmission of HIV (PMTCT)
Outcome: rates of premature births | 0 | {"evidence_spans": [{"end": 29069, "start": 28913, "text": "fe) was comparable in the HAART and scARV for PMTCT groups: 6.7% and 5.6%, respectively (p = 0.80). No significant difference in the rates of premature birt"}], "id": "11439", "pmcid": "1949842", "prompt_id": "11439", "split_group_id": "1949842", "votes": {"0"... |
Background
Highly active antiretroviral treatment (HAART) has only been recently recommended for HIV-infected pregnant women requiring treatment for their own health in resource-limited settings. However, there are few documented experiences from African countries. We evaluated the short-term (4 wk) and long-term (12 ... | Intervention: Highly active antiretroviral treatment (HAART) group
Comparator: antiretroviral (scARV) prevention of mother-to-child transmission of HIV (PMTCT)
Outcome: low birth weight | 1 | {"evidence_spans": [{"end": 29281, "start": 29070, "text": "s (gestational age <37 wk) was noted between the two groups (7.8% and 7.9% respectively, p = 1.00). However, a higher proportion of low birth weight (<2,500 g) was observed in neonates whose mothers had received"}, {"end": 29281, "start": 29079, "text": "ional... |
Background
No therapies have been proven to persistently improve the outcome of HTLV-I-associated myelopathy. Clinical benefit has been reported with zidovudine and with lamivudine in observational studies. We therefore conducted a randomised, double blind, placebo controlled study of six months combination therapy wi... | Intervention: zidovudine 300 mg plus lamivudine 150 mg twice daily (the active arm)
Comparator: matching zidovudine and lamivudine placebo tablets (the placebo arm)
Outcome: HTLV-I proviral load | 0 | {"evidence_spans": [{"end": 12454, "start": 11968, "text": "inary frequency data (2 in each group) and baseline frequency was unknown for another patient in the placebo group. All are excluded from the analysis.\r\nFigure 1Changes in timed 13 meter walk observed during the study period.\r\nLaboratory markers of efficac... |
Background
No therapies have been proven to persistently improve the outcome of HTLV-I-associated myelopathy. Clinical benefit has been reported with zidovudine and with lamivudine in observational studies. We therefore conducted a randomised, double blind, placebo controlled study of six months combination therapy wi... | Intervention: zidovudine 300 mg plus lamivudine 150 mg twice daily (the active arm)
Comparator: matching zidovudine and lamivudine placebo tablets (the placebo arm)
Outcome: Total Lymphocytes (106/L) | 0 | {"evidence_spans": [{"end": 12787, "start": 12727, "text": "able 3Laboratory outcome measures during randomised treatmen"}, {"end": 14577, "start": 14437, "text": "D8b Lymphocytes (106/L)\r\n+65.8 (31.3)\r\n-23.5 (13.7)\r\n0.04\r\nCD8b %\r\n+1.4 (1.2)\r\n-0.7 (1.1)\r\n0.16\r\nCD25a %\r\n-0.8 (1.8)\r\n-0.2 (1.3)\r\n0.82... |
A total of 474 adult patients with malignant glioma (astrocytoma) grade 3 or 4 were randomised into an MRC study (BR2) comparing 45 Gy (in 20 fractions over 4 weeks) with 60 Gy (in 30 fractions over 6 weeks) of radiotherapy given post-operatively. Using 2:1 randomisation, 318 patients were allocated the 60 Gy course an... | Intervention: 45 Gy (in 20 fractions over 4 weeks) with 60 Gy (in 30 fractions over 6 weeks)
Comparator: baseline
Outcome: median survival | 1 | {"evidence_spans": [{"end": 685, "start": 490, "text": "They suggest a statistically significant prolongation of median survival from 9 months in the 45 Gy group to 12 months in the 60 Gy group (hazard ratio = 0.75, chi 2 = 7.36, d.f. = 1, P = 0.007)."}], "id": "11450", "pmcid": "1977696", "prompt_id": "11450", "split_... |
Objectives:
The supermarket industry now services many customers through online food shopping over the Internet. The Internet shopping process offers a novel opportunity for the modification of dietary patterns. The aim of this study was to evaluate the effects on consumers' purchases of saturated fat of a fully autom... | Intervention: fully automated advice that recommended specific switches from selected products higher in saturated fat to alternate similar products lower in saturated fat
Comparator: control received general non-specific advice about how to eat a diet lower in saturated fat
Outcome: The amount of saturated fat in the ... | -1 | {"evidence_spans": [{"end": 1516, "start": 1350, "text": "about three people. The amount of saturated fat in the foods purchased by the intervention group was 0.66% lower (95% confidence interval 0.48\u20130.84, p < 0.001) than i"}, {"end": 1517, "start": 1351, "text": "bout three people. The amount of saturated fat in... |
Objectives:
The supermarket industry now services many customers through online food shopping over the Internet. The Internet shopping process offers a novel opportunity for the modification of dietary patterns. The aim of this study was to evaluate the effects on consumers' purchases of saturated fat of a fully autom... | Intervention: fully automated advice that recommended specific switches from selected products higher in saturated fat to alternate similar products lower in saturated fat
Comparator: control received general non-specific advice about how to eat a diet lower in saturated fat
Outcome: the average cost of the food | 0 | {"evidence_spans": [{"end": 1682, "start": 1518, "text": "the control group. The effects of the intervention were sustained over consecutive shopping episodes, and there was no difference in the average cost of the food bo"}], "id": "11452", "pmcid": "1574360", "prompt_id": "11452", "split_group_id": "1574360", "votes"... |
Background
Soluble fibers lower serum lipids, but are difficult to incorporate into products acceptable to consumers. We investigated the physiological effects of a concentrated oat β-glucan on cardiovascular disease (CVD) endpoints in human subjects. We also compared the fermentability of concentrated oat β-glucan wi... | Intervention: 6 grams/day concentrated oat β-glucan
Comparator: 6 grams/day dextrose (control)
Outcome: LDL cholesterol | -1 | {"evidence_spans": [{"end": 17955, "start": 17859, "text": "erol dropped 0.3 \u00b1 0.1 mmol/L (mean \u00b1 SEM) in subjects consuming oat \u03b2-glucan. LDL cholesterol d"}, {"end": 29745, "start": 29521, "text": "the cardiovascular benefits of dietary fiber. These include improvement in postprandial glucose and insul... |
Background
Soluble fibers lower serum lipids, but are difficult to incorporate into products acceptable to consumers. We investigated the physiological effects of a concentrated oat β-glucan on cardiovascular disease (CVD) endpoints in human subjects. We also compared the fermentability of concentrated oat β-glucan wi... | Intervention: 6 grams/day concentrated oat β-glucan
Comparator: 6 grams/day dextrose (control)
Outcome: HDL cholesterol | 0 | {"evidence_spans": [{"end": 18042, "start": 17956, "text": "d not change significantly within the placebo group; the mean decrease was 0.04 mmol/L"}], "id": "11455", "pmcid": "1847683", "prompt_id": "11455", "split_group_id": "1847683", "votes": {"0": 2}} |
Background
Soluble fibers lower serum lipids, but are difficult to incorporate into products acceptable to consumers. We investigated the physiological effects of a concentrated oat β-glucan on cardiovascular disease (CVD) endpoints in human subjects. We also compared the fermentability of concentrated oat β-glucan wi... | Intervention: 6 grams/day concentrated oat β-glucan
Comparator: 6 grams/day dextrose (control)
Outcome: Triglycerides | 1 | {"evidence_spans": [{"end": 18353, "start": 18249, "text": "sed 0.09 \u00b1 0.1 mmol/L (mean \u00b1 SEM) in the treatment group, but this change was not significantly differe"}], "id": "11456", "pmcid": "1847683", "prompt_id": "11456", "split_group_id": "1847683", "votes": {"1": 1}} |
A double-blind trial was performed on 12 client-owned dogs suffering from acute and painful dermatitis. Clinically these cases represented pyotraumatic dermatitis and pyotraumatic folliculitis. Six dogs were injected with meloxicam and 6 were given placebo. Signs of pain were recorded on a visual analogue scale before ... | Intervention: meloxicam
Comparator: placebo
Outcome: pain (painscores on VAS in millimetres ) | 0 | {"evidence_spans": [{"end": 7465, "start": 7327, "text": "e scores had decreased by an average of 28.3 percent for group one and 8.3 percent for group 2 (Figs. 1, 2, 3).\r\nGroups compared using the"}], "id": "11457", "pmcid": "1764200", "prompt_id": "11457", "split_group_id": "1764200", "votes": {"0": 1}} |
A double-blind trial was performed on 12 client-owned dogs suffering from acute and painful dermatitis. Clinically these cases represented pyotraumatic dermatitis and pyotraumatic folliculitis. Six dogs were injected with meloxicam and 6 were given placebo. Signs of pain were recorded on a visual analogue scale before ... | Intervention: meloxicam
Comparator: placebo
Outcome: pain (painscore on VAS was compared as a percentage) | -1 | {"evidence_spans": [{"end": 7597, "start": 7466, "text": "Wilcoxon two-sample test yielded p = 0.064 when comparing decrease of painscores on VAS in millimetres (Fig. 4).\r\nWhen the groups' "}], "id": "11458", "pmcid": "1764200", "prompt_id": "11458", "split_group_id": "1764200", "votes": {"-1": 2}} |
Background
Postprandial lipemia is an independent risk factor for coronary heart disease. Single bouts of moderate exercise may lower this risk, but the minimum duration of moderate intensity exercise that still lowers postprandial lipemia is not known. We, therefore, performed a dose-response study with a normal, dai... | Intervention: activity trials (30, 60, or 90 min of treadmill walking at 50% of their individual VO2max)
Comparator: no physical activity
Outcome: triacylglycerol (TAG) | 0 | {"evidence_spans": [{"end": 1524, "start": 1334, "text": "sults\r\nPostprandial lipemia (dAUC of triacylglycerol) was, compared to the control trial, +2% (P = 1.00), -14% (P = 0.24), and -15% (P = 0.23) in the 30, 60, and 90 min walking trials, respe"}, {"end": 8304, "start": 8118, "text": " 1.78 (0.17) mmol\u00b7 L-1,... |
Background
Postprandial lipemia is an independent risk factor for coronary heart disease. Single bouts of moderate exercise may lower this risk, but the minimum duration of moderate intensity exercise that still lowers postprandial lipemia is not known. We, therefore, performed a dose-response study with a normal, dai... | Intervention: activity trials (30, 60, or 90 min of treadmill walking at 50% of their individual VO2max)
Comparator: no physical activity
Outcome: Insulin concentration | 0 | {"evidence_spans": [{"end": 10187, "start": 9852, "text": "was observed. Profiles of glucose, glucagon, fatty acids (FA), and glycerol are presented in Figure 5A\u2013D.\r\nFigure 3Insulin concentration for the inactivity and the activity (30, 60, or 90 min treadmill walking) trials. For better readability the symbols ... |
Background
Postprandial lipemia is an independent risk factor for coronary heart disease. Single bouts of moderate exercise may lower this risk, but the minimum duration of moderate intensity exercise that still lowers postprandial lipemia is not known. We, therefore, performed a dose-response study with a normal, dai... | Intervention: activity trials (30, 60, or 90 min of treadmill walking at 50% of their individual VO2max)
Comparator: no physical activity
Outcome: postprandial insulin | 0 | {"evidence_spans": [{"end": 10434, "start": 10378, "text": "mean, standard error of the mean) for the inactivity and"}], "id": "11461", "pmcid": "1277845", "prompt_id": "11461", "split_group_id": "1277845", "votes": {"0": 2}} |
Introduction
β2 agonists have several properties that could be beneficial in acute lung injury (ALI). We therefore chose to study the effect of inhaled β2 agonist use (salbutamol) on duration and severity of ALI.
Methods
We undertook a retrospective chart review of 86 consecutive mechanically ventilated patients w... | Intervention: inhaled salbutamol 'high dose' ≥ 2.2 mg/day
Comparator: inhaled salbutamol 'low dose' <2.2 mg/day
Outcome: days alive and free of acute lung injury (ALI) | 1 | {"evidence_spans": [{"end": 970, "start": 815, "text": "ively. The high dose salbutamol group had significantly more days alive and free of ALI than the low dose group (12.2 \u00b1 4.4 days versus 7.6 \u00b1 1.9 days, p ="}], "id": "11468", "pmcid": "1550825", "prompt_id": "11468", "split_group_id": "1550825", "votes":... |
Background
The apparent interactions between the mechanisms of action of non-steroidal anti-inflammatory drugs (NSAIDS) and steroids suggest that co-therapy may provide beneficial inflammatory and pain relief in the absence of side effects. The aim of the study was to compare the effect of co-administered dexamethason... | Intervention: dexamethasone (prophylactic 8 mg and postoperative 4 mg IV) and diclofenac K (50 mg Oral before and after surgery)
Comparator: diclofenac K alone (as with first group)
Outcome: relief of pain | 1 | {"evidence_spans": [{"end": 1401, "start": 1269, "text": "sults\r\nCo-administration of dexamethasone and diclofenac K was significantly superior to diclofenac alone for the relief of pain (P "}], "id": "11472", "pmcid": "1291385", "prompt_id": "11472", "split_group_id": "1291385", "votes": {"1": 2}} |
Background
The apparent interactions between the mechanisms of action of non-steroidal anti-inflammatory drugs (NSAIDS) and steroids suggest that co-therapy may provide beneficial inflammatory and pain relief in the absence of side effects. The aim of the study was to compare the effect of co-administered dexamethason... | Intervention: dexamethasone (prophylactic 8 mg and postoperative 4 mg IV) and diclofenac K (50 mg Oral before and after surgery)
Comparator: diclofenac K alone (as with first group)
Outcome: facial swelling up to post-operative 48 hour | -1 | {"evidence_spans": [{"end": 1463, "start": 1269, "text": "sults\r\nCo-administration of dexamethasone and diclofenac K was significantly superior to diclofenac alone for the relief of pain (P < 0.05), and facial swelling up to post-operative 48 hour (P <"}, {"end": 16583, "start": 16270, "text": "vely and postoperative... |
Background
The apparent interactions between the mechanisms of action of non-steroidal anti-inflammatory drugs (NSAIDS) and steroids suggest that co-therapy may provide beneficial inflammatory and pain relief in the absence of side effects. The aim of the study was to compare the effect of co-administered dexamethason... | Intervention: dexamethasone (prophylactic 8 mg and postoperative 4 mg IV) and diclofenac K (50 mg Oral before and after surgery)
Comparator: diclofenac K alone (as with first group)
Outcome: trismus relief | 0 | {"evidence_spans": [{"end": 1576, "start": 1464, "text": "0.05). However, there was no significant difference for trismus relief between the two medication protocols (P >"}, {"end": 1576, "start": 1473, "text": "wever, there was no significant difference for trismus relief between the two medication protocols (P >"}], ... |
Objectives:
The respiratory pathogen Chlamydia pneumoniae (C. pneumoniae) produces acute and chronic lung infections and is associated with asthma. Evidence for effectiveness of antichlamydial antibiotics in asthma is limited. The primary objective of this pilot study was to investigate the feasibility of performing a... | Intervention: Azithromycin
Comparator: placebo, plus usual community care
Outcome: Overall asthma symptoms | -1 | {"evidence_spans": [{"end": 18657, "start": 18446, "text": "vored azithromycin for all asthma symptom and activity outcomes except work (\u22120.02 units). Overall asthma symptoms improved in the azithromycin group (+0.55) and worsened in the placebo group (\u22120.13). The effect"}, {"end": 18899, "start": 18446, "tex... |
Objectives:
The respiratory pathogen Chlamydia pneumoniae (C. pneumoniae) produces acute and chronic lung infections and is associated with asthma. Evidence for effectiveness of antichlamydial antibiotics in asthma is limited. The primary objective of this pilot study was to investigate the feasibility of performing a... | Intervention: Azithromycin
Comparator: placebo, plus usual community care
Outcome: Maximum overall symptom improvement | 1 | {"evidence_spans": [{"end": 18555, "start": 18446, "text": "vored azithromycin for all asthma symptom and activity outcomes except work (\u22120.02 units). Overall asthma sym"}, {"end": 19196, "start": 19000, "text": "presents overall asthma symptom patterns by study month according to treatment allocation. Maximum ove... |
Background
Past studies suggested that tumor necrosis factor (TNF) assisted anti-tumor treatment and intensified the sensitivity of chemotherapy. However its clinical application has been curbed because of its low purity, high dosage, and strong toxicity. This research, through perspective random clinical control expe... | Intervention: rmhTNF 4 × 106u/m2 was given to the trial group, from the 1st to 7th days, the 11th to 17th days combined with chemotherapy course
Comparator: control group was given only the same chemotherapy as the trial group.
Outcome: the KPS score | 1 | {"evidence_spans": [{"end": 1799, "start": 1631, "text": "roups. After the treatment the KPS is 89.00 \u00b1 9.92 in the trial group, and 84.17 \u00b1 8.84 in the control group, with a significant difference between the two groups (P = "}], "id": "11479", "pmcid": "529310", "prompt_id": "11479", "split_group_id": "5293... |
Studies in children suggest a weak association between blood lead concentration and blood pressure. To understand this better, we tested the strength of the association in children with elevated blood lead concentrations and whether succimer chelation changed blood pressure as it did blood lead. In a randomized clinica... | Intervention: succimer chelation
Comparator: placebo
Outcome: systolic blood pressure and diastolic blood pressure | 0 | {"evidence_spans": [{"end": 1106, "start": 814, "text": "During 1\u20135 years of follow-up, children in the succimer group had systolic blood pressure 1.09 (95% confidence interval, 0.27\u20131.90) mmHg higher than did untreated children in a model with repeated measurements, but the difference in diastolic blood pres... |
Objective. The aim of this study is to verify whether consolidation chemotherapy with Cisplatin improves disease-free survival and/or overall survival in patients affected by epithelial ovarian cancer.
Methods. A multicenter study examined 122 randomized patients in complete remission as judged by laparoscopy or lapar... | Intervention: Cisplatin at 100 mg/m2
Comparator: no further treatment (nihil group)
Outcome: Median overall survival | 0 | {"evidence_spans": [{"end": 10423, "start": 10269, "text": "ion of ovarian cancer.\r\nMedian overall survival was 87 months for the cisplatin arm (82.0% at 3 years) and 89 months for the nihil arm (80.3% at 3 years) "}], "id": "11488", "pmcid": "1074719", "prompt_id": "11488", "split_group_id": "1074719", "votes": {"0"... |
Objective. The aim of this study is to verify whether consolidation chemotherapy with Cisplatin improves disease-free survival and/or overall survival in patients affected by epithelial ovarian cancer.
Methods. A multicenter study examined 122 randomized patients in complete remission as judged by laparoscopy or lapar... | Intervention: Cisplatin at 100 mg/m2
Comparator: no further treatment (nihil group)
Outcome: Median disease free survival | 0 | {"evidence_spans": [{"end": 1174, "start": 1067, "text": "d median disease-free survival (66 months with Cisplatin vs. 73 in the nihil group) were similar in both ar"}, {"end": 10726, "start": 10423, "text": "(p=0.66, log rank test). Median disease free survival was 68 months (range 1.4-170.0) for the Cisplatin arm (62... |
Introduction
Research indicates that low fruit and vegetable intake is a risk factor for many chronic diseases. Despite large-scale education campaigns, the great majority of Americans do not consume recommended levels. We tested the ability of a single brief interactive experience of the Little by Little CD-ROM to in... | Intervention: the Little by Little CD-ROM plus two reminder telephone calls,
Comparator: a stress management CD-ROM (control condition)
Outcome: fruit and vegetable intake | 1 | {"evidence_spans": [{"end": 1261, "start": 1106, "text": "group. The Little by Little group with reminder calls increased daily intake by 1.32 fruits/vegetables, an 86% greater increase than the control group (P ="}, {"end": 18329, "start": 18139, "text": "groups than in the stress-reduction group (Table 2). There were... |
Introduction
Research indicates that low fruit and vegetable intake is a risk factor for many chronic diseases. Despite large-scale education campaigns, the great majority of Americans do not consume recommended levels. We tested the ability of a single brief interactive experience of the Little by Little CD-ROM to in... | Intervention: a one-time experience with the Little by Little CD-ROM
Comparator: a stress management CD-ROM (control condition)
Outcome: fruit and vegetable intake | 1 | {"evidence_spans": [{"end": 1105, "start": 935, "text": "sults\r\nTwo months after the one-time experience with the CD-ROMs, both intervention groups reported significantly higher intakes of fruits and vegetables than the control"}], "id": "11491", "pmcid": "1253473", "prompt_id": "11491", "split_group_id": "1253473", ... |
Introduction
Research indicates that low fruit and vegetable intake is a risk factor for many chronic diseases. Despite large-scale education campaigns, the great majority of Americans do not consume recommended levels. We tested the ability of a single brief interactive experience of the Little by Little CD-ROM to in... | Intervention: the Little by Little CD-ROM plus two reminder telephone calls,
Comparator: a stress management CD-ROM (control condition)
Outcome: Stage of Readiness for Change | 1 | {"evidence_spans": [{"end": 19952, "start": 19727, "text": " stress-reduction group had a substantial increase in fruit and vegetable intake (1.32 servings).\r\n\r\nIncrease in Stage of Readiness for Change\r\nBoth Little by Little groups increased in Stage of Readiness for Change, but only"}], "id": "11492", "pmcid": ... |
Abstract Hyperlipidemia and increased degree of oxidative stress are among the important risk factors for Atherosclerosis in renal transplant recipients (RTR). The Medical treatment of hyperlipidemia in RTR because of drugs side effects has been problematic, therefore alternative methods ... | Intervention: one clove of garlic (1 gr) by chewing or swallowing for two months
Comparator: pre garlic period
Outcome: HDL, LDL and cyclosporine serum levels | 0 | {"evidence_spans": [{"end": 1599, "start": 1479, "text": " LDL and cyclosporine serum levels had no significant differences by both of swallowing and chewing routes"}], "id": "11497", "pmcid": "1173136", "prompt_id": "11497", "split_group_id": "1173136", "votes": {"0": 2}} |
Objective
To assess the effects of a 6-month angiotensin-converting enzyme (ACE) inhibitor intervention on myocardial ischaemia.
Method
We randomized 389 patients with stable coronary artery disease to double-blind treatment with ramipril 5 mg/day (n = 133), ramipril 1.25 mg/day (n = 133), or placebo (n = 123). Fo... | Intervention: ramipril 5 mg/day (n = 133), ramipril 1.25 mg/day
Comparator: placebo
Outcome: ST-segment depression (STD) duration (min), Ischaemic burden, Maximum STD (mV) | 0 | {"evidence_spans": [{"end": 10131, "start": 10011, "text": "um STD (mV)\r\nBaseline\r\n133\r\n0.23\r\n0.09\r\n133\r\n0.24\r\n0.10\r\n123\r\n0.26\r\n0.11\r\n\r\n1 month\r\n123\r\n0.18\r\n0.12\r\n121\r\n0.20\r\n0.13\r\n1"}, {"end": 10262, "start": 10011, "text": "um STD (mV)\r\nBaseline\r\n133\r\n0.23\r\n0.09\r\n133\r\n0... |
Background
Supporting 21st century health care and the practice of evidence-based medicine (EBM) requires ubiquitous access to clinical information and to knowledge-based resources to answer clinical questions. Many questions go unanswered, however, due to lack of skills in formulating questions, crafting effective se... | Intervention: PICO templates (Protocol A or Protocol B)
Comparator: Protocol C, the standard PubMed Web interface
Outcome: precision score | 0 | {"evidence_spans": [{"end": 1914, "start": 1584, "text": "erface. (Question 1: A = 35%, B = 28%, C = 20%; Question 2: A = 5%, B = 6%, C = 4%; Question 3: A = 1%, B = 0%, C = 0%) 95% confidence intervals were calculated for the precision for each question using a lower boundary of zero. However, the 95% confidence limit... |
Background
Two different enzyme preparations, agalsidase alfa (ReplagalTM, Shire) and beta (FabrazymeTM, Genzyme), are registered for treatment of Fabry disease. We compared the efficacy of and tolerability towards the two agalsidase preparations administered at identical protein dose in a randomized controlled open l... | Intervention: agalsidase alfaf 0.2 mg/kg
Comparator: agalsidase beta of 0.2 mg/kg
Outcome: median cardiac mass | 0 | {"evidence_spans": [{"end": 25301, "start": 24852, "text": " throughout the study. Changes in co-medication during the trial were minimal: in 3 patients (2 in the agalsidase alfa group and one in the agalsidase beta group) a dose change of angiotensin-converting enzyme inhibitor or angiotensin-I blocker was made, and i... |
Background
Two different enzyme preparations, agalsidase alfa (ReplagalTM, Shire) and beta (FabrazymeTM, Genzyme), are registered for treatment of Fabry disease. We compared the efficacy of and tolerability towards the two agalsidase preparations administered at identical protein dose in a randomized controlled open l... | Intervention: agalsidase alfa of 0.2 mg/kg biweekly
Comparator: agalsidase beta of 0.2 mg/kg
Outcome: Glomerular filtration rate (GFR) | 0 | {"evidence_spans": [{"end": 26388, "start": 26219, "text": " Median change was \u221211% (\u221223 g, range \u2212167 to 136 g, p\u200a=\u200a0.51) following agalsidase alfa treatment and \u221215% (\u221246 g, range \u2212226 to 131 g, p\u200a=\u200a0.17) after 12 months of aga"}, {"end": 26602, "start": 26462, "text"... |
Background
Two different enzyme preparations, agalsidase alfa (ReplagalTM, Shire) and beta (FabrazymeTM, Genzyme), are registered for treatment of Fabry disease. We compared the efficacy of and tolerability towards the two agalsidase preparations administered at identical protein dose in a randomized controlled open l... | Intervention: agalsidase alfa 0.2 mg/kg biweekly
Comparator: agalsidase beta of 0.2 mg/kg
Outcome: Urinary protein | 0 | {"evidence_spans": [{"end": 27586, "start": 27060, "text": " 12 months of treatment was observed for the combined groups, which did not reach significance for the two treatment groups separately (p\u200a=\u200a0.09 and 0.17 for agalsidase alfa and beta, respectively).\r\n\r\nSecondary endpoint: Glomerular filtration ra... |
Background
Two different enzyme preparations, agalsidase alfa (ReplagalTM, Shire) and beta (FabrazymeTM, Genzyme), are registered for treatment of Fabry disease. We compared the efficacy of and tolerability towards the two agalsidase preparations administered at identical protein dose in a randomized controlled open l... | Intervention: agalsidase alfa 0.2 mg/kg
Comparator: agalsidase beta of 0.2 mg/kg
Outcome: Pain Score | 0 | {"evidence_spans": [{"end": 28550, "start": 28392, "text": "lowing 12 and 24 months of treatment (agalsidase alfa at 12 months: 0.30 g/24 h (range 0.08 to 2.83, p\u200a=\u200a0.35) and at 24 months: 0.27 g/24 h (range 0.10 to 1."}, {"end": 28627, "start": 28392, "text": "lowing 12 and 24 months of treatment (agalsidase... |
Background
Two different enzyme preparations, agalsidase alfa (ReplagalTM, Shire) and beta (FabrazymeTM, Genzyme), are registered for treatment of Fabry disease. We compared the efficacy of and tolerability towards the two agalsidase preparations administered at identical protein dose in a randomized controlled open l... | Intervention: agalsidase alfa 0.2 mg/kg
Comparator: agalsidase beta of 0.2 mg/kg
Outcome: GL-3 in urine and plasma | 0 | {"evidence_spans": [{"end": 29895, "start": 29806, "text": " (GL-3 in urine and plasma)\r\nAnti-agalsidase antibodies and GL-3 levels in urine and plas"}, {"end": 31212, "start": 30762, "text": " 1350, p\u200a=\u200a0.04) in the agalsidase alfa group and 265 nmol/24 hr (range \u22121216 to 1450, p\u200a=\u200a0.66) in ... |
Objectives:
We evaluated the hypothesis that cyclooxygenase (COX) inhibitor use might have counteracted a beneficial effect of postmenopausal hormone therapy, and account for the absence of cardioprotection in the Women's Health Initiative hormone trials. Estrogen increases COX expression, and inhibitors of COX such a... | Intervention: conjugated estrogens 0.625 mg with medroxyprogesterone acetate 2.5 mg daily
Comparator: placebo
Outcome: The hazard ratio for myocardial infarction/coronary death | 0 | {"evidence_spans": [{"end": 1682, "start": 1447, "text": "COX inhibitor use. The hazard ratio for myocardial infarction/coronary death with estrogen plus progestin was 1.13 (95% confidence interval 0.68\u20131.89) among non-users of COX inhibitors, and 1.35 (95% confidence interval 0.86\u20132.10) amon"}], "id": "11517... |
Objectives:
We evaluated the hypothesis that cyclooxygenase (COX) inhibitor use might have counteracted a beneficial effect of postmenopausal hormone therapy, and account for the absence of cardioprotection in the Women's Health Initiative hormone trials. Estrogen increases COX expression, and inhibitors of COX such a... | Intervention: conjugated estrogens 0.625 mg
Comparator: placebo
Outcome: The hazard ratio for myocardial infarction/coronary death | 0 | {"evidence_spans": [{"end": 1868, "start": 1447, "text": "COX inhibitor use. The hazard ratio for myocardial infarction/coronary death with estrogen plus progestin was 1.13 (95% confidence interval 0.68\u20131.89) among non-users of COX inhibitors, and 1.35 (95% confidence interval 0.86\u20132.10) among continuous user... |
PREVENT was the first prospective, randomized placebo-controlled study of intracoronary beta radiotherapy with 32P. A total of 105 patients with de novo or restenotic lesions, treated by stenting or balloon angioplasty, received 0 (control), 16, 20, or 24 Gy to a depth of 1 mm beyond the lumen surface. Rates of resteno... | Intervention: intracoronary beta radiotherapy with 32P
Comparator: control
Outcome: Rates of restenosis at the target site plus adjacent segments | -1 | {"evidence_spans": [{"end": 539, "start": 303, "text": " Rates of restenosis (50% diameter stenosis or more) were significantly lower in radiotherapy patients at the target site (8% compared with 39%, P = 0.012) and at the target site plus adjacent segments (22% compared with 50%, P = 0.018)"}, {"end": 540, "start": 30... |
Background
Approaches to limiting exposure to antiretroviral therapy (ART) drugs are an active area of HIV therapy research. Here we present longitudinal follow-up of a randomized, open-label, single-center study of the immune, viral, and safety outcomes of structured therapy interruptions (TIs) in patients with chron... | Intervention: three successive fixed TIs of 2, 4, and 6 wk, with intervening resumption of therapy with resuppression for 4 wk before subsequent interruption
Comparator: 40 wk of continuous therapy, with a final open-ended TI in both treatment groups
Outcome: the time to viral rebound (>5,000 copies/ml) | 0 | {"evidence_spans": [{"end": 1343, "start": 1094, "text": "on.\r\nThere was no difference between the groups in time to viral rebound during the open-ended TI (continuous therapy/single TI, median [interquartile range] = 4 [1\u20138] wk, n = 21; repeated TI, median [interquartile range] = 5 [4\u20138] wk, n = 21; p = 0"... |
Background
The primary aim of this study is to demonstrate the feasibility of utilizing doxycycline to suppress matrix metalloproteinase-9 (MMP-9) in brain arteriovenous malformations (AVMs).
Methods
Ex-vivo treatment of AVM tissues: Intact AVM tissues were treated with doxycycline for 48 hours. Active and total M... | Intervention: doxycycline (100 mg)
Comparator: placebo
Outcome: matrix metalloproteinase-9 (MMP-9) | -1 | {"evidence_spans": [], "id": "11522", "pmcid": "547916", "prompt_id": "11522", "split_group_id": "547916", "votes": {"-1": 1}} |
Background
Recent electroconvulsive therapy (ECT) efficacy studies of right unilateral (RUL) ECT may not apply to real life clinics with a wide range of patients with major depressive episodes.
Methods
The study included two groups of patients. In addition to a homogeneous group of patients with major depression a... | Intervention: electroconvulsive therapy (ECT) treatment forpatients with major depression according to DSM-IV criteria with severity of the major depressive episode > 16 scores on 17-item Hamilton Rating Scale for Depression (HDRS) (Group 1)
Comparator: electroconvulsive therapy (ECT) treatment patients with less ... | 1 | {"evidence_spans": [{"end": 19122, "start": 18892, "text": "th baseline. cCognitive risk = MMSE change < 0%. dP = 0.0036 using ANCOVA with pre-ECT HDRS score and age as covariates. eP = 0.1803 using ANCOVA with pre-ECT MMSE score and age as covariates.\r\nThe improvement in HDRS score was hi"}], "id": "11523", "pmcid":... |
Background
Recent electroconvulsive therapy (ECT) efficacy studies of right unilateral (RUL) ECT may not apply to real life clinics with a wide range of patients with major depressive episodes.
Methods
The study included two groups of patients. In addition to a homogeneous group of patients with major depression a... | Intervention: electroconvulsive therapy (ECT) treatment forpatients with major depression according to DSM-IV criteria with severity of the major depressive episode &gt; 16 scores on 17-item Hamilton Rating Scale for Depression (HDRS) (Group 1)
Comparator: electroconvulsive therapy (ECT) treatment patients with l... | 1 | {"evidence_spans": [{"end": 17932, "start": 17734, "text": "he initial seizure threshold refer to mean \u00b1 SD values after the first treatment. mC, millicoulombs.\r\n\r\nOutcome of the treatment\r\nGroup 1 vs. Group 2\r\nThe number of responders vs. nonresponders was "}], "id": "11524", "pmcid": "65527", "prompt_id"... |
Background
Recent electroconvulsive therapy (ECT) efficacy studies of right unilateral (RUL) ECT may not apply to real life clinics with a wide range of patients with major depressive episodes.
Methods
The study included two groups of patients. In addition to a homogeneous group of patients with major depression a... | Intervention: electroconvulsive therapy (ECT) treatment forpatients with major depression according to DSM-IV criteria with severity of the major depressive episode &amp;gt; 16 scores on 17-item Hamilton Rating Scale for Depression (HDRS) (Group 1)
Comparator: electroconvulsive therapy (ECT) treatment patients wi... | 0 | {"evidence_spans": [{"end": 20396, "start": 19946, "text": "\nThe number of treatments was not different between Group 1 and Group 2 in the ITT sample (Table 3) or among study completers (median, mean, range: 8.0, 8.3, 4\u201314 vs. 8.0, 8.8, 4\u201314, P = 0.5844).\r\nThe mean MMSE scores improved in the Group 1 patie... |
Background
Online computer-tailored smoking cessation programs have not yet been compared directly.
Objective
To compare the efficacy of two Internet-based, computer-tailored smoking cessation programs.
Methods
Randomized controlled trial conducted in 2003-2004. Visitors to a smoking cessation website were ran... | Intervention: interactive smoking cessation program
Comparator: modified program
Outcome: quit rates in the contemplation stage | 1 | {"evidence_spans": [{"end": 2093, "start": 1927, "text": " smokers. While we found statistically significant differences in quit rates in smokers in the contemplation stage favoring the original program (OR=1.54, CI 1.18-2.0"}, {"end": 16787, "start": 16519, "text": "eline current smokers (abstinence rates: 10.9% vs 8.... |
Background
Online computer-tailored smoking cessation programs have not yet been compared directly.
Objective
To compare the efficacy of two Internet-based, computer-tailored smoking cessation programs.
Methods
Randomized controlled trial conducted in 2003-2004. Visitors to a smoking cessation website were ran... | Intervention: interactive smoking cessation program
Comparator: modified program
Outcome: quit rates in the precontemplation stage | 0 | {"evidence_spans": [{"end": 2282, "start": 2095, "text": " P=.002), no between-group differences in quit rates were observed in smokers in the precontemplation (OR=1.07, CI 0.36-3.14, P=.91) and preparation (OR=1.15, CI 0.97-1.37, P=.10) stages "}], "id": "11531", "pmcid": "1550632", "prompt_id": "11531", "split_group_... |
Background
Online computer-tailored smoking cessation programs have not yet been compared directly.
Objective
To compare the efficacy of two Internet-based, computer-tailored smoking cessation programs.
Methods
Randomized controlled trial conducted in 2003-2004. Visitors to a smoking cessation website were ran... | Intervention: interactive smoking cessation program
Comparator: modified program
Outcome: quit rates in the preparation stage | 0 | {"evidence_spans": [{"end": 2282, "start": 2095, "text": " P=.002), no between-group differences in quit rates were observed in smokers in the precontemplation (OR=1.07, CI 0.36-3.14, P=.91) and preparation (OR=1.15, CI 0.97-1.37, P=.10) stages "}], "id": "11532", "pmcid": "1550632", "prompt_id": "11532", "split_group_... |
Background
Despite a growing literature on the efficacy of behavioral weight loss interventions, we still know relatively little about the long terms effects they have on HRQL. Therefore, we conducted a study to investigate the immediate post-intervention (6 months) and long-term (12 and 24 months) effects of clinical... | Intervention: clinical weight loss program
Comparator: extended care group
Outcome: Mean weight loss | 0 | {"evidence_spans": [{"end": 18222, "start": 18099, "text": "nalysis examined changes in the composite scales and indicated a significant multivariate Time main effect (F (6, 85) = 4.3"}], "id": "11535", "pmcid": "1553435", "prompt_id": "11535", "split_group_id": "1553435", "votes": {"0": 1}} |
Background
To compare the efficacy and safety of budesonide/formoterol (Symbicort®) with formoterol (Oxis®) in the treatment of patients with acute asthma who showed evidence of refractoriness to short-acting β2-agonist therapy.
Methods
In a 3 hour, randomized, double-blind study, a total of 115 patients with acut... | Intervention: budesonide/formoterol (320/9 μg, 2 inhalations at t = -5 minutes and 2 inhalations at 0 minutes [total dose 1280/36 μg]
Comparator: formoterol (9 μg, 2 inhalations at t = -5 minutes and 2 inhalations at 0 minutes [total dose 36 μg]
Outcome: Vital signs, ECG parameters and oxygen saturation | 0 | {"evidence_spans": [{"end": 20511, "start": 20245, "text": "r study drug administration were 3.82 and 3.88 mmol/L for the budesonide/formoterol and formoterol groups, respectively. The corresponding mean pre-dose values were 3.83 and 4.01 mmol/L, respectively. Abnormally low values (<\r\nVital signs, ECG parameters and... |
Background
To compare the efficacy and safety of budesonide/formoterol (Symbicort®) with formoterol (Oxis®) in the treatment of patients with acute asthma who showed evidence of refractoriness to short-acting β2-agonist therapy.
Methods
In a 3 hour, randomized, double-blind study, a total of 115 patients with acut... | Intervention: budesonide/formoterol (320/9 μg, 2 inhalations at t = -5 minutes and 2 inhalations at 0 minutes [total dose 1280/36 μg]
Comparator: formoterol (9 μg, 2 inhalations at t = -5 minutes and 2 inhalations at 0 minutes [total dose 36 μg]
Outcome: heart rate | -1 | {"evidence_spans": [{"end": 20696, "start": 20369, "text": " corresponding mean pre-dose values were 3.83 and 4.01 mmol/L, respectively. Abnormally low values (<\r\nVital signs, ECG parameters and oxygen saturation also showed only small changes over time during the course of the study. There were no statistically sign... |
Background
To determine whether the use of an electronic, sensor based stethoscope affects the cardiac auscultation skills of undergraduate medical students.
Methods
Forty eight third year medical students were randomized to use either an electronic stethoscope, or a conventional acoustic stethoscope during clinic... | Intervention: electronic stethoscope
Comparator: conventional acoustic stethoscope
Outcome: The number of questionnaires scored | 0 | {"evidence_spans": [{"end": 9763, "start": 9692, "text": "dents were from the group using the electronic stethoscope.) Three ques"}], "id": "11543", "pmcid": "1131903", "prompt_id": "11543", "split_group_id": "1131903", "votes": {"0": 2}} |
Background
To determine whether the use of an electronic, sensor based stethoscope affects the cardiac auscultation skills of undergraduate medical students.
Methods
Forty eight third year medical students were randomized to use either an electronic stethoscope, or a conventional acoustic stethoscope during clinic... | Intervention: electronic stethoscope
Comparator: conventional acoustic stethoscope
Outcome: grading the murmurs | 0 | {"evidence_spans": [{"end": 10383, "start": 10162, "text": "nts with a 95% CI of (-0.33 \u2013 1.53) points (p = 0.65). (Figure 1)\r\nFigure 1The number of students distributed on intervals of points.\r\nWhen grading the murmurs, the students using conventional stethoscopes had 27 correct "}, {"end": 11913, "start": 11... |
Background
To determine whether the use of an electronic, sensor based stethoscope affects the cardiac auscultation skills of undergraduate medical students.
Methods
Forty eight third year medical students were randomized to use either an electronic stethoscope, or a conventional acoustic stethoscope during clinic... | Intervention: electronic stethoscope
Comparator: conventional acoustic stethoscope
Outcome: characterising murmurs | 0 | {"evidence_spans": [{"end": 10600, "start": 10384, "text": "nd 27 incorrect responses, whereas the students using the electronic stethoscope had 29 correct and 22 incorrect responses (p = 0.47). On characterising murmurs the group using conventional stethoscopes had 45 correc"}], "id": "11545", "pmcid": "1131903", "pro... |
Background
To determine whether the use of an electronic, sensor based stethoscope affects the cardiac auscultation skills of undergraduate medical students.
Methods
Forty eight third year medical students were randomized to use either an electronic stethoscope, or a conventional acoustic stethoscope during clinic... | Intervention: electronic stethoscope
Comparator: conventional acoustic stethoscope
Outcome: report of false murmurs | 0 | {"evidence_spans": [{"end": 10821, "start": 10594, "text": "correct and 66 incorrect responses, while the students using the electronic stethoscope had 42 correct and 66 incorrect responses (p = 0.76). When tested for report of false murmurs, the group using conventional stethoscopes ha"}, {"end": 10830, "start": 10600... |
Background
Clinical trials of tiotropium have principally recruited patients from secondary care with more severe chronic obstructive pulmonary disease (COPD), and typically had included limitation of concomitant medication. In primary care, which is the most common setting for COPD management, many patients may have ... | Intervention: tiotropium 18 μg via the HandiHaler®
Comparator: placebo
Outcome: forced expiratory volume in 1 second (FEV1) | 1 | {"evidence_spans": [{"end": 1226, "start": 1116, "text": "sults\r\nAt Week 12, median improvement in trough FEV1 response with tiotropium versus placebo was 0.06 L (p = 0"}], "id": "11547", "pmcid": "1913915", "prompt_id": "11547", "split_group_id": "1913915", "votes": {"1": 2}} |
Background
Clinical trials of tiotropium have principally recruited patients from secondary care with more severe chronic obstructive pulmonary disease (COPD), and typically had included limitation of concomitant medication. In primary care, which is the most common setting for COPD management, many patients may have ... | Intervention: tiotropium 18 μg via the HandiHaler®
Comparator: placebo
Outcome: forced vital capacity (FVC) | 1 | {"evidence_spans": [{"end": 1373, "start": 1303, "text": "erity. Median improvement in FVC at 2, 6 and 12 weeks was 0.12 L (p < "}, {"end": 17266, "start": 17142, "text": " (p = 0.0102) (Table 2).\r\n\r\nSecondary endpoints\r\nTrough FEV1 response also showed an improvement with tiotropium compared wi"}], "id": "11548"... |
Background
Clinical trials of tiotropium have principally recruited patients from secondary care with more severe chronic obstructive pulmonary disease (COPD), and typically had included limitation of concomitant medication. In primary care, which is the most common setting for COPD management, many patients may have ... | Intervention: tiotropium 18 μg via the HandiHaler®
Comparator: placebo
Outcome: The percentage of patients with ≥1 exacerbation | -1 | {"evidence_spans": [{"end": 1511, "start": 1373, "text": "0.001). The percentage of patients with \u22651 exacerbation was reduced (tiotropium 9.5%; placebo 17.9%; p = 0.0147), independent of disease s"}, {"end": 1512, "start": 1374, "text": ".001). The percentage of patients with \u22651 exacerbation was reduced (tiot... |
Introduction
Prone position is effective in mechanically ventilated patients to improve oxygenation. It is unknown if prone position affects gastric emptying and the ability of continued enteral feeding.
Aim
To determine tolerance of enteral feeding by measuring gastric residual volumes in enterally fed patients d... | Intervention: feeding in supine position
Comparator: feeding in prone position
Outcome: The median volume of administered enteral feeds | 0 | {"evidence_spans": [{"end": 982, "start": 837, "text": "\nResults\r\nThe median volume of administered enteral feeds was 95 ml after 6 hours in supine position and 110 ml after 6 hours in prone position ("}], "id": "11550", "pmcid": "37407", "prompt_id": "11550", "split_group_id": "37407", "votes": {"0": 2}} |
Introduction
Prone position is effective in mechanically ventilated patients to improve oxygenation. It is unknown if prone position affects gastric emptying and the ability of continued enteral feeding.
Aim
To determine tolerance of enteral feeding by measuring gastric residual volumes in enterally fed patients d... | Intervention: feeding in supine position
Comparator: feeding in prone position
Outcome: The mean gastric residual volume after feeding for 3 hours | 0 | {"evidence_spans": [{"end": 6943, "start": 6743, "text": "pine position (P = 0.59).\r\nThe mean gastric residual volume after feeding for 3 hours in the prone position was 59.7 ml (range, 0-200 ml), compared with 59.5 ml (range, 0-180 ml) after 3 hours in the "}], "id": "11551", "pmcid": "37407", "prompt_id": "11551", ... |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.